Systemic Lupus Erythematosus Associated with Extreme Hypertriglyceridemia

Pediatrics and Neonatology

Volumn 49, Issue 2, 2008, Pages 35-38

  Huang, Chin Sung ^a   Wu, Wei Fong ^a,b  

^a TAIPEI CITY HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

hypertriglyceridemia; lipoprotein lipase; systemic lupus erythematosus; type V hyperlipo proteinemia

Indexed keywords

ANTILIPEMIC AGENT; ATORVASTATIN; AUTOANTIBODY; HYDROXYCHLOROQUINE; LIPOPROTEIN LIPASE; PREDNISOLONE; STEROID; TRIACYLGLYCEROL;

ADD ON THERAPY; ADOLESCENT; ARTICLE; CASE REPORT; DISEASE DURATION; DISEASE SEVERITY; DRUG DOSE REDUCTION; ECHOGRAPHY; ENZYME DEFICIENCY; FEMALE; FEVER; FOLLOW UP; HUMAN; HYPERTRIGLYCERIDEMIA; LABORATORY TEST; LOW FAT DIET; OUTPATIENT CARE; PHYSICAL EXAMINATION; STEROID THERAPY; SYSTEMIC LUPUS ERYTHEMATOSUS; TRIACYLGLYCEROL BLOOD LEVEL;

ADOLESCENT; CHYLOMICRONS; FEMALE; HUMANS; HYPERTRIGLYCERIDEMIA; LIPOPROTEIN LIPASE; LUPUS ERYTHEMATOSUS, SYSTEMIC; PREDNISOLONE;

EID: 54149112916     PISSN: 18759572     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1875-9572(08)60009-1     Document Type: Article

References (14)

1. Beaumont J.L. Autoimmune hyperlipidemia: an atherogenic metabolic disease of immune origin. Rev Eur Clin Biol 15 (1970) 1037-1048
2. Beaumont J.L., Berard M., Antonucci M., Delplanque B., and Vranckx R. Inhibition of lipoprotein lipase activity by a monoclonal immunoglobulin in autoimmune hyperlipidemia. Atherosclerosis 26 (1977) 67-77
3. Glueck C.J., Levy R.I., Glueck H.I., Gralnick H.R., Greten H., and Fredrickson D.S. Acquired type I hyperlipoproteinemia with systemic lupus erythematosus, dysglobulinemia and heparin resistance. Am J Med 47 (1969) 318-324
4. Falko J.M., Williams J.C., Harvey D.G., Weidman S.W., Schonfeld G., and Dodson W.E. Hyperlipoproteinemia and multifocal neurologic dysfunction in systemic lupus erythematosus. J Pediatr 95 (1979) 523-529
5. Paucillo P., De Simone B., Rubba P., and Mancini M. A case of association between type I hyperlipoproteinemia and systemic lupus erythematosus (SLE): effects of steroid treatment. J Endocrinol Invest 9 (1986) 517-520
6. Stem M.P., Kolterman O.G., McDevitt H., and Reaven G.M. Acquired type 3 hyperlipoproteinemia: report of three cases associated with systemic lupus erythematosus and diabetic ketoacidosis. Arch Intern Med 130 (1972) 817-821
7. Alverson D.C., and Chase H.P. Systemic lupus erythematosus in childhood presenting as hyperlipoproteinemia. J Pediatr 91 (1977) 72-75
8. Nakane T., Asayama K., Higashida K., et al. Type V hyperlipoproteinemia in systemic lupus erythematosus. Pediatr Int 45 (2003) 352-354
9. Brunzell J.D. Familial lipoprotein lipase deficiency and other causes of the chylomicronemia syndrome. In: Scriver C., Beaudet A.I., Sly W.S., and Valle D. (Eds). The Metabolic and Molecular Basis of Inherited Diseases (1995), McGraw-Hill, New York 1913-1933
10. Borba E.F., Bonfa E., Vinagre C.G.C., Ramires J., and Maranhao R.C. Chylomicron metabolism is markedly altered in systemic lupus erythematosus. Arthritis Rheum 43 (2000) 1033-1040
11. Kihara S., Matsuzawa Y., Kubo M., et al. Autoimmune hyperchylomicronemia. N Engl J Med 320 (1989) 1255-1259
12. Pruneta V., Moulin P., Labrousse F., Bondon P.-J., Ponsin G., and Berthezene F. Characterization of a new case of autoimmune type I hyperlipidemia: long-term remission under immunosuppressive therapy. J Clin Endocrinol Metab 82 (1997) 791-799
13. Tan E.M., Cohen A.S., Fries I.F., et al. The 1982 revised criteria for the classification of systemic lupus erythematosus (SLE). Arthritis Rheum 25 (1982) 1271-1277
14. Beaumont J.L., Carlson L.A., Cooper G.R., Fejfar Z., and Fredrickson D.S. Classification of hyperlipidemias and hyperlipoproteinemias. Bull World Health Organ 43 (1970) 891-915